|
-
andrepharma3
2025-3-14
-
92
0
|
|
-
andrepharma3
2025-3-14
-
82
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|
|
-
andrepharma3
2025-3-14
-
102
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
108
0
|
|
-
andrepharma3
2025-3-14
-
93
0
|
|
-
andrepharma3
2025-3-14
-
93
0
|
|
-
andrepharma3
2025-3-14
-
99
0
|
|
-
andrepharma3
2025-3-14
-
88
0
|
|
-
andrepharma3
2025-3-14
-
88
0
|
|
-
andrepharma3
2025-3-14
-
106
0
|
|
-
andrepharma3
2025-3-14
-
90
0
|
|
-
andrepharma3
2025-3-14
-
95
0
|
|
-
andrepharma3
2025-3-14
-
100
0
|
|
-
andrepharma3
2025-3-14
-
117
0
|
|
-
andrepharma3
2025-3-14
-
88
0
|
|
-
andrepharma3
2025-3-14
-
87
0
|
|
-
andrepharma3
2025-3-14
-
94
0
|